Quantcast

Latest Biologic Stories

2014-12-16 04:21:31

CAMBRIDGE, England, December 16, 2014 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces a further equity investment from Astellas Venture Management

2014-12-13 12:20:50

ReportsandReports.com adds latest reports on Adalimumab Industry for Global and China Markets to its store. DALLAS, Dec.

2014-12-11 16:24:58

First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif. and LONDON, Dec.

2014-12-11 04:21:34

The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.

2014-12-09 23:03:35

Symphogen has licensed the rights to the Selexis SUREtechnology Platform™ and SURE CHO-M Cell Line™ for the development of recombinant monoclonal antibody (MAb) mixtures for the treatment

2014-12-09 04:21:49

DELHI, India, December 9, 2014 /PRNewswire/ -- Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis,


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.